Last reviewed · How we verify
Escitalopram 10mg
At a glance
| Generic name | Escitalopram 10mg |
|---|---|
| Also known as | Lexapro, real drug application |
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant (PHASE4)
- Neuroimaging of Escitalopram in Autism Spectrum Disorder (PHASE2)
- Efficacy and Safety of Probiotics for Anxiety Depression (NA)
- Improving Outcomes in Depression in Primary Care in a Low Resource Setting (PHASE3)
- Escitalopram and Language Intervention for Subacute Aphasia (PHASE2)
- Impact of Escitalopram on Sperm DNA Fragmentation (PHASE2)
- The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry (NA)
- A Study Utilizing Escitalopram in Glioma Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Escitalopram 10mg CI brief — competitive landscape report
- Escitalopram 10mg updates RSS · CI watch RSS
- Wake Forest University Health Sciences portfolio CI